The impact of the Fc modification on functionality was further assessed in antibody-dependent cell-mediated toxicity (ADCC) assays using a panel of infectious molecular clones encoding recently circulating Env sequences obtained from placebo infections in recent clinical trials (HVTN703/HVTN704 and HVTN705). Here, ERVW-1 is linked to infection.